a public good project by the
Synthesis
Company
of California

© 2026

Ellen McErlean | doi.page

0 works0 citations0 h-index

Ellen McErlean

Cleveland Clinic(US)Center for Clinical Research (United States)(US)

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Acute Myocardial Infarction Research, Antiplatelet Therapy and Cardiovascular Diseases, Cancer, Lipids, and Metabolism, Coronary Interventions and Diagnostics

Most-Cited Works

→ Prognostic Value of Myeloperoxidase in Patients with Chest Pain(2003)1,073 cited
→ Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease(2017)781 cited
→ Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol(2011)412 cited
→ Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy(2022)329 cited
→ Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction(2023)142 cited
→ Effects of a Potent and Selective PPAR-α Agonist in Patients With Atherogenic Dyslipidemia or Hypercholesterolemia(2007)129 cited

→ Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease(2020)

115 cited

→ Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study(1999)105 cited

→ Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial(2014)101 cited